204 related articles for article (PubMed ID: 25283372)
1. Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of Trypanosoma brucei.
Ochiana SO; Bland ND; Settimo L; Campbell RK; Pollastri MP
Chem Biol Drug Des; 2015 May; 85(5):549-64. PubMed ID: 25283372
[TBL] [Abstract][Full Text] [Related]
2. Repurposing human PDE4 inhibitors for neglected tropical diseases: design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors.
Amata E; Bland ND; Hoyt CT; Settimo L; Campbell RK; Pollastri MP
Bioorg Med Chem Lett; 2014 Sep; 24(17):4084-9. PubMed ID: 25127163
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).
Woodring JL; Bland ND; Ochiana SO; Campbell RK; Pollastri MP
Bioorg Med Chem Lett; 2013 Nov; 23(21):5971-4. PubMed ID: 24042005
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
Veerman J; van den Bergh T; Orrling KM; Jansen C; Cos P; Maes L; Chatelain E; Ioset JR; Edink EE; Tenor H; Seebeck T; de Esch I; Leurs R; Sterk GJ
Bioorg Med Chem; 2016 Apr; 24(7):1573-81. PubMed ID: 26935942
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP
J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure.
Jansen C; Wang H; Kooistra AJ; de Graaf C; Orrling KM; Tenor H; Seebeck T; Bailey D; de Esch IJ; Ke H; Leurs R
J Med Chem; 2013 Mar; 56(5):2087-96. PubMed ID: 23409953
[TBL] [Abstract][Full Text] [Related]
7. Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.
Blaazer AR; Singh AK; de Heuvel E; Edink E; Orrling KM; Veerman JJN; van den Bergh T; Jansen C; Balasubramaniam E; Mooij WJ; Custers H; Sijm M; Tagoe DNA; Kalejaiye TD; Munday JC; Tenor H; Matheeussen A; Wijtmans M; Siderius M; de Graaf C; Maes L; de Koning HP; Bailey DS; Sterk GJ; de Esch IJP; Brown DG; Leurs R
J Med Chem; 2018 May; 61(9):3870-3888. PubMed ID: 29672041
[TBL] [Abstract][Full Text] [Related]
8. Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors.
de Heuvel E; Singh AK; Edink E; van der Meer T; van der Woude M; Sadek P; Krell-Jørgensen MP; van den Bergh T; Veerman J; Caljon G; Kalejaiye TD; Wijtmans M; Maes L; de Koning HP; Jan Sterk G; Siderius M; de Esch IJP; Brown DG; Leurs R
Bioorg Med Chem; 2019 Sep; 27(18):3998-4012. PubMed ID: 31327675
[TBL] [Abstract][Full Text] [Related]
9. Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).
de Heuvel E; Singh AK; Boronat P; Kooistra AJ; van der Meer T; Sadek P; Blaazer AR; Shaner NC; Bindels DS; Caljon G; Maes L; Sterk GJ; Siderius M; Oberholzer M; de Esch IJP; Brown DG; Leurs R
Bioorg Med Chem; 2019 Sep; 27(18):4013-4029. PubMed ID: 31378593
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogs.
Wang C; Ashton TD; Gustafson A; Bland ND; Ochiana SO; Campbell RK; Pollastri MP
Bioorg Med Chem Lett; 2012 Apr; 22(7):2579-81. PubMed ID: 22370268
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs.
Ochiana SO; Gustafson A; Bland ND; Wang C; Russo MJ; Campbell RK; Pollastri MP
Bioorg Med Chem Lett; 2012 Apr; 22(7):2582-4. PubMed ID: 22377518
[TBL] [Abstract][Full Text] [Related]
12. The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence.
Oberholzer M; Marti G; Baresic M; Kunz S; Hemphill A; Seebeck T
FASEB J; 2007 Mar; 21(3):720-31. PubMed ID: 17167070
[TBL] [Abstract][Full Text] [Related]
13. Homology Modeling and Molecular Dynamics Simulations of Trypanosoma cruzi Phosphodiesterase b1.
Llanos MA; Alberca LN; Larrea SCV; Schoijet AC; Alonso GD; Bellera CL; Gavenet L; Talevi A
Chem Biodivers; 2022 Jan; 19(1):e202100712. PubMed ID: 34813143
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of phosphodiesterase TbrPDEB1 of Trypanosoma brucei contains the signal for integration into the flagellar skeleton.
Luginbuehl E; Ryter D; Schranz-Zumkehr J; Oberholzer M; Kunz S; Seebeck T
Eukaryot Cell; 2010 Oct; 9(10):1466-75. PubMed ID: 20693305
[TBL] [Abstract][Full Text] [Related]
16. Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.
Orrling KM; Jansen C; Vu XL; Balmer V; Bregy P; Shanmugham A; England P; Bailey D; Cos P; Maes L; Adams E; van den Bogaart E; Chatelain E; Ioset JR; van de Stolpe A; Zorg S; Veerman J; Seebeck T; Sterk GJ; de Esch IJ; Leurs R
J Med Chem; 2012 Oct; 55(20):8745-56. PubMed ID: 22963052
[TBL] [Abstract][Full Text] [Related]
17. Surface plasmon resonance biosensor assay for the analysis of small-molecule inhibitor binding to human and parasitic phosphodiesterases.
Siderius M; Shanmugham A; England P; van der Meer T; Bebelman JP; Blaazer AR; de Esch IJ; Leurs R
Anal Biochem; 2016 Jun; 503():41-9. PubMed ID: 27033007
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).
Amata E; Bland ND; Campbell RK; Pollastri MP
Tetrahedron Lett; 2015 May; 56(21):2832-2835. PubMed ID: 25977593
[TBL] [Abstract][Full Text] [Related]
19. PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes.
Jin J; Mazzacuva F; Crocetti L; Giovannoni MP; Cilibrizzi A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511275
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual Screening.
de Heuvel E; Kooistra AJ; Edink E; van Klaveren S; Stuijt J; van der Meer T; Sadek P; Mabille D; Caljon G; Maes L; Siderius M; de Esch IJP; Sterk GJ; Leurs R
Front Chem; 2020; 8():608030. PubMed ID: 33553105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
